![Understanding the blood clot issue behind the AstraZeneca vaccine and its safety - Hamilton Health Sciences Understanding the blood clot issue behind the AstraZeneca vaccine and its safety - Hamilton Health Sciences](https://www.hamiltonhealthsciences.ca/wp-content/uploads/2021/04/CovidStats_07-04-21-final_Page_2-scaled.jpg)
Understanding the blood clot issue behind the AstraZeneca vaccine and its safety - Hamilton Health Sciences
![Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet](https://www.thelancet.com/cms/attachment/c0547203-d7c7-4471-bd9b-1440f4613981/gr1_lrg.jpg)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
![WHO statement on AstraZeneca COVID-19 vaccine safety signals - PAHO/WHO | Pan American Health Organization WHO statement on AstraZeneca COVID-19 vaccine safety signals - PAHO/WHO | Pan American Health Organization](https://www.paho.org/sites/default/files/styles/max_1500x1500/public/card/2021-03/covine-19-vaccine-3-1500x850.jpg?itok=FfcauOGB)